A Phase II Study of Intravenous Exatecan Mesylate (DX-8951f) Administered Daily for Five Days Every Three Weeks to Patients with Metastatic Adenocarcinoma of the Colon or Rectum

2004 ◽  
Vol 22 (1) ◽  
pp. 53-61 ◽  
Author(s):  
Melanie E. Royce ◽  
Eric K. Rowinsky ◽  
Paulo M. Hoff ◽  
John Coyle ◽  
Robert DeJager ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Adenocarcinoma ◽  
Adenocarcinoma Of The Colon ◽  
Exatecan Mesylate

A phase II study of gemcitabine (G), bevacizumab (B), and erlotinib (E) in locally advanced (LAPC) and metastatic adenocarcinoma (MPC) of the pancreas

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 15515-15515
Author(s):  
L. S. Blaszkowsky ◽  
A. X. Zhu ◽  
T. A. Abrams ◽  
C. C. Earle ◽  
E. Kwak ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Metastatic Adenocarcinoma

A phase II study of gefitinib as a dirst-line therapy of advanced or metastatic adenocarcinoma of the lung in lifetime non-smokers

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7072-7072 ◽  
Author(s):  
D. H. Lee ◽  
J. Y. Han ◽  
H. G. Lee ◽  
J. J. Lee ◽  
E. K. Lee ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Adenocarcinoma ◽  
Adenocarcinoma Of The Lung ◽  
Line Therapy

scholarly journals Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

2017 ◽  
Vol 23 (3) ◽  
pp. 277 ◽  
Author(s):  
Pat Gulhati ◽  
Kanwal Raghav ◽  
Rachna Shroff ◽  
Gauri Varadhachary ◽  
Milind Javle ◽  
...  
Keyword(s):  
Small Bowel ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Ampulla Of Vater ◽  
Metastatic Adenocarcinoma ◽  
Wild Type
Sign in / Sign up

Export Citation Format

Share Document